BUSINESS COMBINATION AGREEMENT BY AND AMONG PRIVETERRA ACQUISITION CORP., PRIVETERRA MERGER SUB, INC. AND AEON BIOPHARMA, INC. DATED AS OF DECEMBER 12, 2022Business Combination Agreement • July 31st, 2023 • Strathspey Crown Holdings Group, LLC • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 31st, 2023 Company Industry JurisdictionThis BUSINESS COMBINATION AGREEMENT (this “Agreement”), dated as of December 12, 2022, is made by and among Priveterra Acquisition Corp., a Delaware corporation (“Priveterra”), Priveterra Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and AEON Biopharma, Inc., a Delaware corporation (the “Company”). Priveterra, Merger Sub and the Company shall be referred to herein from time to time collectively as the “Parties” (and each a “Party”). Capitalized terms used herein have the meanings set forth in Section 1.1 and Section 1.2.
BUSINESS COMBINATION AGREEMENT BY AND AMONG Priveterra Acquisition Corp., PRIVETERRA MERGER SUB, INC. AND AEON Biopharma, INC. DATED AS OF DECEMBER 12, 2022Business Combination Agreement • December 13th, 2022 • Priveterra Acquisition Corp. • Blank checks • Delaware
Contract Type FiledDecember 13th, 2022 Company Industry JurisdictionThis BUSINESS COMBINATION AGREEMENT (this “Agreement”), dated as of December 12, 2022, is made by and among Priveterra Acquisition Corp., a Delaware corporation (“Priveterra”), Priveterra Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and AEON Biopharma, Inc., a Delaware corporation (the “Company”). Priveterra, Merger Sub and the Company shall be referred to herein from time to time collectively as the “Parties” (and each a “Party”). Capitalized terms used herein have the meanings set forth in Section 1.1 and Section 1.2.